Under the Patent Act [35 USC § 101], patents may be issued to whoever invests or discovers any new and useful composition of matter. The United States Supreme Court held that a naturally occurring DNA segment is a product of nature and is not patent eligible. But a synthetically created strand of DNA called cDNA is patent eligible. Association For Molecular Pathology v. Myriad Genetics, Inc. (U.S. Sup. Ct.; June 13, 2013) 133 S.Ct. 2107, [186 L.Ed.2d 124].
Leave a Reply
You must be logged in to post a comment.